1. Upregulation of PD-L1 on monocytes and dendritic cells by HIV-1 derived TLR ligands
- Author
-
Sylvie LeGall, Angela Meier, Judith Hellman, Mark A. Brockman, Galit Alter, Daniel G. Kavanagh, Hendrik Streeck, Todd J. Suscovich, Aranya Bagchi, Harlyn K. Sidhu, and Marcus Altfeld
- Subjects
Immunology ,HIV Infections ,Ligands ,Article ,B7-H1 Antigen ,Monocytes ,Flow cytometry ,Antigen ,Downregulation and upregulation ,Antigens, CD ,PD-L1 ,medicine ,Humans ,Immunology and Allergy ,Receptor ,medicine.diagnostic_test ,biology ,Monocyte ,Toll-Like Receptors ,virus diseases ,Dendritic Cells ,Dendritic cell ,Flow Cytometry ,Up-Regulation ,Cell biology ,Infectious Diseases ,medicine.anatomical_structure ,B7-1 Antigen ,HIV-1 ,biology.protein ,B7-2 Antigen - Abstract
Increased PD-L1 expression has been reported in HIV-1-infected individuals, but the mechanisms leading to PD-L1 upregulation remain to be elucidated. Here we demonstrate that HIV-1-derived Toll-like receptor (TLR)7/8 ligands can induce MyD88-dependent upregulation of PD-L1 on plasmacytoid dendritic cells, myeloidic dendritic cells and monocytes. These data suggest a mechanism through which HIV-1-derived TLR ligands might contribute to the functional impairment of virus-specific PD-1-positive T cells by inducing the upregulation of PD-L1 on antigen-presenting cells.
- Published
- 2008
- Full Text
- View/download PDF